Enter inventor name

Ralph M Steinman

USPTO Granted Patents = 24

EPO Patents = 1

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 375(Granted Patents)

Company Filing History:

21 out of 712

The Rockefeller University

patents

3 out of 40

Argos Therapeutics, Inc.

patents

1 out of 272

Kyowa Hakko Kirin Co., Limited

patents

4. 3 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2014

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8865871 - Antibodies and kits for immunodetection of epitope tags (2014-10-21),

2. 8563308 - Culture-expanded T suppressor cells and methods of use thereof (2013-10-22),

3. 8399628 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof (2013-03-19),

4. 8114634 - Methods, systems and reagents for improved immunodetection (2012-02-14),

5. 7989203 - Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells (2011-08-02),

6. 7943345 - Methods, systems and reagents for improved immunodetection (2011-05-17),

7. 7923247 - Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens (2011-04-12),

8. 7837990 - In vivo expanded NKT cells and methods of use thereof (2010-11-23),

9. 7659119 - Method and compositions for obtaining mature dendritic cells (2010-02-09),

10. 7622442 - Protein belonging to the TNF superfamily involved in signal transduction and methods of use thereof (2009-11-24),

11. 7442377 - Protective antigen of epstein barr virus (2008-10-28),

12. 7393927 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof (2008-07-01),

13. 7198948 - Methods and compositions for obtaining mature dendritic cells (2007-04-03),

14. 7129037 - Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells (2006-10-31),

15. 7019119 - Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof (2006-03-28),

Title: The Innovative Journey of Ralph M. Steinman: A Pioneer in Immunology

Introduction: Ralph M. Steinman, a distinguished inventor based in Westport, CT, has made remarkable contributions to the field of immunology. With 24 patents to his name, his work has fundamentally influenced the understanding and treatment of immune-related diseases.

Latest Patents: Among his notable inventions, two stand out due to their significant implications in medical science. The first is titled "Antibodies and kits for immunodetection of epitope tags," which introduces antibodies recognizing new epitope tags. This invention is complemented by kits that facilitate the detection of these epitope tags or fusion proteins containing them. The second is "Culture-expanded T suppressor cells and methods of use thereof," which focuses on culture-expanded T suppressor cells derived from CD25CD4T cells. This invention provides methods for producing antigen-specific T suppressor cells and explores their utility in modulating autoimmune diseases and preventing transplantation rejection.

Career Highlights: Ralph M. Steinman's professional journey includes significant tenures at prestigious institutions, notably The Rockefeller University. His research has paved the way for future innovations in immunotherapy, and his patents reflect a commitment to advancing medical science.

Collaborations: Throughout his career, Steinman has collaborated with esteemed colleagues such as Nina Bhardwaj and Kayo Inaba. These partnerships have enriched his research and contributed to groundbreaking discoveries in the immunology field.

Conclusion: Ralph M. Steinman’s innovative spirit and dedication have solidified his legacy in the realm of immunology. His numerous patents not only demonstrate his inventive prowess but also have the potential to change the landscape of disease treatment. As the field continues to evolve, Steinman’s contributions remain a cornerstone for future advancements and discoveries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com